Moonshot AI closed a larger-than-planned $3.5 billion funding round at a $35 billion valuation, Bloomberg reported July 29 — roughly eight times its December level, priced on the strength of the July 16 Kimi K3 launch. [1]

The lead investor is the state. China's National AI Industry Investment Fund anchored the round, which means the mark Washington's hawks will cite as evidence of a private-sector race was set substantially by public money. The round was the lab's third in six months. [1] [2]

Two further claims remain reports, not events: a still-larger raise at roughly $50 billion pre-money, and a Hong Kong IPO. Neither has happened; a private valuation is a mark, not realized value. The round's full investor list and terms beyond the state fund's lead role are undisclosed in the day's record. [1]

Bloomberg frames China catching up to U.S. lab valuations; the open-weights community notes the adoption paradox underneath — American firms quietly build on Kimi K3 while Washington debates a Chinese-model crackdown, and Kimi K3's actual U.S. enterprise adoption beyond anecdote is unmeasured. The state-backed lead undercuts both frames: this is not quite a market verdict, and not quite a private one either. The June context — three rounds in six months — is labeled as background, not as part of Wednesday's record. [2]

-- DAVID CHEN, Beijing